Abrdn Life Sciences Investors (HQL)
NYSE
Closed
Aug 25, 2026
Day's Range
21.5652 wk Range
13.57Overview - HQL - Abrdn Life Sciences Investors
Key Statistics
Valuation
Enterprise Value
679.68M
P/E (Trailing)
‪3.37‬
Price / Sales (TTM)
‪7.62‬
Price / Book
‪1.21‬
Profitability
Profit Margin
‪17,856.98%‬
Operating Margin
‪-516.52%‬
Return on Assets
‪-0.61%‬
Return on Equity
‪41.42%‬
Ownership
Shares Outstanding
30.40M
Held by Insiders
‪0.0020%‬
Held by Institutions
‪26.47%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪19.79‬
200-Day Avg
‪17.73‬
Dividends
Payout Ratio
‪28.77%‬
Frequency
Quarterly
Peers - HQL - Abrdn Life Sciences Investors
Peer Comparison
Compared with companies in Asset Management listed on NYSE.
- HQLNYSEAbrdn Life Sciences Investors680.53MMarket Cap+36.46%52-week change3.37P/E (Trailing)‪17,856.98%‬Profit Margin
- BLKNYSEBlackRock, Inc.191.17BMarket Cap+3.13%52-week change27.70P/E (Trailing)‪24.08%‬Profit Margin
- BXNYSEBlackstone Inc.171.41BMarket Cap-19.54%52-week change32.06P/E (Trailing)‪22.72%‬Profit Margin
- COPNYSEConocoPhillips160.19BMarket Cap+26.70%52-week change17.82P/E (Trailing)‪14.40%‬Profit Margin
- HDBNYSEHDFC Bank Limited ADR121.33BMarket Cap-53.83%52-week change16.39P/E (Trailing)‪26.78%‬Profit Margin
- BKNYSEThe Bank of New York Mellon Corporation95.92BMarket Cap+35.81%52-week change17.02P/E (Trailing)‪28.72%‬Profit Margin
- BNNYSEBrookfield Corporation94.02BMarket Cap-3.61%52-week change78.00P/E (Trailing)‪1.77%‬Profit Margin
Profile Summary - HQL - Abrdn Life Sciences Investors
About
Abrdn Life Sciences Investors is a closed-end equity mutual fund with a primary focus on long-term capital appreciation through investments in the life sciences sector. Managed by abrdn Inc., the fund seeks opportunities in both U.S. and global markets, allocating capital predominantly to companies engaged in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
